Atezolizumab AND Hyaluronidase-tqjs

MAY 15, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Tecentriq Hybreza (Efficacy)

U.S. Food and Drug Administration

FDA supplemental approval for a fixed-dose combination formulation; regulatory action does not itself report clinical trial efficacy data or comparative outcomes.